Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Exclusion Criteria

• •Known hypersensitivity for any active ingredient or constituent
• •Pregnancy or lactation
• •Medically documented history of severe psychiatric disturbance, including severe depression, suicidal ideation or suicide attempt
• •Medically documented history of severe heart disease, including unstable or uncontrolled cardiac disease, within the last 6 months
• •Severely weakening medical condition, including chronic renal insufficiency or creatinine clearance \<50 mL/minute
• •Hepatitis of immunologic origin or medically documented history of auto-immune disease
• •Severe hepatic disorder or decompensated cirrhosis
• •Pre-existing thyroid disorder, except if under control with classical treatment
• •Epilepsy or central nervous system disorder
• •Hemoglobin pathology, eg, thalassaemia, sickle cell anemia